Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Liver Cirrhosis

• Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis
• To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis
• A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)
• ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial
• Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia
• Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies
• Oral Branched-chain Amino Acid Supplementation for Cirrhotic Patients With Sarcopenia
• Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and Ascites
• A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly
• Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced Hypotension
• Pentoxifylline Plus Carvedilol vs Carvedilol Monotherapy in Preventing New Decompensation in Stable Cirrhotic Patients With Prior Decompensation
• A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
• EGCG for Hepatocellular Carcinoma Chemoprevention
• NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients
• A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis
• Hydroxynidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
• A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV
• A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
• Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.
• DOAC in Patients With Child B Liver Cirrhosis
• Rifaximin for Preventing Progression and Complications in Patients With Decompensated Liver Cirrhosis
• Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
• Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
• Allopurinol and Quality of Life
• LiveSMART Trial to Prevent Falls in Patients With Cirrhosis
• Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments
• A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis
• A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis
• Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome
• Empagliflozin in Patients With Cirrhosis and Ascites
• Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosis
• To Study the Hemodynamic Response of Early Addition of Carvedilol to Terlipressin in Acute Variceal Bleed in Child's B and C Cirrhosis
• COffee and Metabolites Modulating the Gut MicrobiomE in coloN canCER
• Synbiotics Interventions for Managing Cirrhosis and Its Complications
• Opioid Sparing Anesthesia in Patients With Liver Cirrhosis Undergoing Liver Resection
• Coagulation in Cirrhosis
• Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding
• Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
• Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With Diabetes
• HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes
• Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease
• Allopurinol to Prevent Cirrhosis Related Morbidities
• Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA).
• Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
• Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)
• Allopurinol Versus Simvastatin to Prevent Complications of Liver Cirrhosis
• Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease
• A Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis
• Single Dose Escalation of PHIN-214 in Child-Pugh A Liver Cirrhotics
• Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial
• Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes
• Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis
• 20% Albumin vs. Balanced Salt Solution as Resuscitation Fluid in Cirrhosis With Sepsis Induced Hypotension
• A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis
• HRS-AKI Treatment With TIPS in Patients With Cirrhosis
• Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis
• Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial
• A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury
• Different Doses of ZED1227 vs. Placebo in NAFLD
• To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.
• Growth Hormone in Decompensated Liver Cirrhosis
• Probiotics and Hemodynamic Changes in Cirrhosis
• Effect of Imatinib in Advance Liver Fibrosis Patients
• Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
• To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis.
• Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286
• Composition for Treating Cirrhosis and Liver Cancer (SB-1121)
• Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B
• Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its Complication
• Hydronidone for the Treatment of Liver Fibrosis Associated With Chronic Viral Hepatitis B Phase 3 Trial.
• Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis
• Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis.
• A Trial to Improve Quality of Life in People With Cirrhosis
• To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)
• Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices
• Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites
• Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
• Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
• Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen
• Extension Study of Carvedilol RCT Study
• Empagliflozin in Diuretic Refractory Ascites
• Efficacy of Simvastatin in Alcoholic Liver Fibrosis
• Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)
• Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF)
• Sildenafil for Liver Fibrosis in Adolescents and Adults After Fontan Operation
• Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis
• A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia
• Danazol for Treatment of Cytopenias in Patients With Cirrhosis
• Study in Healthy Adults Evaluating PF-07202954
• A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis
• Avatrombopaq In Patients With Cirrhosis
• Comparison of Bolus Versus Continuous Infusion of Terlipressin Cirrhotic Patients With Septic Shock.
• Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis.
• Single-dose PK Assessment of Oral Proglumide in Those With Hepatic Impairment
• Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension
• Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis
• Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy
• The Clinical Application of Tauroursodeoxycholic Acid in Patients With Liver Fibrosis.
• Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal Hypertension
• Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV With Hemophilia.
• Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.
• Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects
• HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis
• Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Patients With PBC
• Angiotensin 2 for AKI After OLT
• Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes
• A Study of EDP-297 in Healthy Subjects
• Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis
• 68Ga-FAPI PET/CT in Liver Fibrosis Patients
• Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Compensated Liver Cirrhosis
• Efficacy of Vitamin C on AKI Outcomes in Critically Ill Cirrhotics With Multidrug-resistant Bacterial Infections.
• Tranexamic Acid for Acute Upper Gastrointestinal Bleed in Cirrhosis
• A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects
• Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial
• To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.
• Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis
• Anticoagulation Therapy After Splenectomy in Cirrhosis Patient
• Effect of Naltrexone in Achieving and Maintaining Abstinence From Alcohol in Patients With Cirrhosis.
• Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis
• Terlipression Prevent Developing of Acute Kidney Injury During Upper-gastroentestinal Bleeding
• Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.
• Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
• Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.
• Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis
• A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)
• Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)
• HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients
• Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
• Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis
• Prophylactic Antibiotics in Admitted Cirrhotics
• Comparison of Diuretic Effect With Furosemide Alone Versus the Combination of Furosemide and Albumin in Cirrhotic Patients
• Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated Cirrhosis
• Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis
• Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis
• Erlotinib for Hepatocellular Carcinoma Chemoprevention
• Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis
• Antibiotic Prophylaxis in Patients Undergoing GVO
• Granulocyte-Colony Stimulating Factor (G-CSF) as Optimizing Therapy for Pediatric Liver Transplantation
• A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites
• Ivabradine in Cirrhotic Cardiomyopathy
• Pirfenidone and Advanced Liver Fibrosis.
• A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis
• Rifamycin in Minimal Hepatic Encephalopathy
• Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
• Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis
• Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.
• Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis
• Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites
• A Study of Oryz-Aspergillus Enzyme and Pancreatin Tablet in Patients With Cirrhosis and Malnutrition
• Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis
• Sorafenib PK in Patients With Advanced HCC and Child-Pugh B
• Plasma Exchange in Acute on Chronic Liver Failure
• Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis
• Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)
• Efficacy and Safety of Testosterone Therapy in Improving Sarcopenia in Men With Cirrhosis.
• Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs
• Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis Patients
• Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis
• Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT)
• Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver Fibrosis
• Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver Fibrosis
• GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCT
• The Comparison of Changes of QTc, Tp-e Interval, and Tp-e/QT Ratio, Tp-e/QTc Ratio on the ECG During Living Donor Liver Transplantation Under Desflurane and Total Intravenous Anesthesia -Randomized Controlled Trial
• OCR002-SP103 - Oral Immediate Release Study
• To Study the Efficacy and Safety of TIPS (Trans Intrahepatic Portosystemic Shunt) Versus Self Expanding Metallic Stent (SEMS) in the Management of Refractory Variceal Bleed in Cirrhotics.
• A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis
• A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects
• TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)
• FMT in Cirrhosis and Hepatic Encephalopathy
• Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development
• Beta-blockers for Oesophageal Varices
• Effect of Some Drugs on Liver Fibrosis
• N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO Trial
• Carvedilol for Prevention of Esophageal Varices Progression
• MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)
• The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment
• Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVR
• An Evaluation of the Safety and Efficacy of NTZ on Collagen Turnover in NASH Patients With Fibrosis
• Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis
• Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C
• Study of OCA Evaluating Pharmacokinetics and Safety in Patients With PBC and Hepatic Impairment
• Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
• Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis
• A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers
• Tadalafil for Erectile Dysfunction in Patients With Cirrhosis
• First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis
• Management of Decompensated HCV Cirrhotic Patients
• Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis
• A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
• A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
• Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites
• Safety, Tolerability and Pharmacodynamics of SYNB1020
• A Study of Experimental Medication BMS-986036 Given to Healthy Participants
• Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
• A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C
• G-CSF in Decompensated Cirrhosis: an Open Label Trial
• Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis
• Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy
• Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?
• In Vivo Determination of Cytochrome P450 Activities in Patients With Liver Cirrhosis
• Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension
• Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis
• Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunode
• Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b
• Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
• Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis
• Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis
• PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)
• The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices
• Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction
• To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.
• Oral Fecal Transplant in Cirrhosis
• Simvastatin Plus Rifaximin in Decompensated Cirrhosis
• Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in Cirrhosis
• Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis
• Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With Cirrhosis
• Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue
• Autologous Endothelial Progenitor Cell Therapy for Reversal of Liver Cirrhosis
• Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites
• Ramelteon for Treatment of Insomnia in Cirrhosis
• A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis
• Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C Cirrhosis
• Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
• Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV
• AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
• PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosis
• Anticoagulation for Advanced Cirrhotic Patients After TIPS
• Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis
• Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
• Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension
• Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders
• Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome
• Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics
• Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
• Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis
• FDGal PET/CT to Detect Hepatocellular Carcinoma
• Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.
• Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment
• TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV
• Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients
• Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction
• Branched-chain Amino Acid (BCAA) on Progression of Advanced Liver Disease
• A Follow-up Evaluation Study of PRI-724-1101
• Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.
• Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
• Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
• Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients
• The Establishment of Multiple Point Prediction Model About Tacrolimus Metabolic Differences Based on Genetic Network After Liver Transplantation and the Application of Multicenter
• Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis
• A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
• Study to Investigate Tolerability and Efficacy of MK5172 / MK8742 Without Ribavirin for 12 Weeks in Patients With Chronic HCV G1b Infection With Compensated Cirrhosis
• Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1
• Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patients
• The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding
• [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer
• Serelaxin To Lower Portal Pressure
• Multicenter Prospective Randomized Trial of the Effect of Rivaroxaban on Survival and Development of Complications of Portal Hypertension in Patients With Cirrhosis
• Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients
• Cyclobenzaprine in Muscle Cramps With Liver Cirrhosis
• Gabapentin in Treatment of Muscle Cramps in Patients With Liver Cirrhosis
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
• To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis
• The Effect of Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy in Cirrhotic Patients With Esophagogastric Varices
• The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCT
• Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC)
• Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis
• Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection
• Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics
• A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body
• To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis
• Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis
• ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis
• A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients
• Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices
• Surrogate Markers of Portal Pressure
• A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis
• TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
• Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)
• Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis
• Metformin Experience on Minimal Hepatic Encephalopathy
• To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock
• To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.
• To Evaluate the Safety and Efficacy of Sofosbuvir and Ribavirin in Patients With HCV (Genotype 3) Related Decompensated Cirrhosis
• Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
• Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension
• Granulocyte Colony Stimulating Factor And Growth Hormone In Cirrhosis Of Liver: An Open Label Study
• Alfapump-albumin Replacement Therapy
• Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal Bacterial
• Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis
• Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis
• Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver Resection
• Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy
• The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis
• The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal Bleeding
• IBAT Inhibitor A4250 for Cholestatic Pruritus
• Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis
• Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis
• Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
• Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis
• Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis Patients
• An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis
• Primary Prevention Hepatocellular Carcinoma by Metformin
• Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails
• Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
• Safety and Efficacy of Baclofen for Treatment of Muscle Spasms in Patients With Cirrhosis: A Pilot Study
• Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis
• A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
• A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients
• A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH
• Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
• To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism
• A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)
• A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting Conditions
• Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation
• Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV
• Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir
• A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated Cirrhosis
• Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance
• A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
• A Study of IDN-6556 in Subjects With Liver Cirrhosis
• Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)
• Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C
• Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis
• Baclofen in the Treatment of Muscle Cramps in Patients With Cirrhosis
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infectio
• Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis
• Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
• Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis
• An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis
• Pilot Study of FFP104 Dose Escalation in PBC Subjects
• Rifaximin Reduces the Complications of Decompensated Cirrhosis: a Randomized Controlled Trial
• Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites
• LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis
• Evaluation of Renal Blood Flow Using Contrast Enhanced Ultrasound for Differential Diagnosis of Acute Kidney Injury in Cirrhotic Patients: A Pilot Study
• A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
• Simvastatin Effect on Portal Hypertension
• Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
• Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis
• Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis
• Rifaximin Predicts the Complications of Decompensated Cirrhosis
• Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis
• Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
• Treatment of Cirrhosis-related Hepatocellular Carcinoma With the Intrahepatic Arterial Injection of an Emulsion of Lipiodol and Idarubicin (Zavedos®): Phase I Study
• Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy
• A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)
• A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial
• Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer
• A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
• Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis
• Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
• A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Viru
• Optimized Treatment and Regression of HBV-induced Early Cirrhosis
• Optimized Treatment and Regression of HBV-induced Liver Fibrosis
• Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF
• Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV
• Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis
• Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
• Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis
• Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis
• Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
• A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
• Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients
• New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
• Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Subjects With Primary Biliary Cirrhosis
• Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis
• Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia
• Quality of Life and Nutritional Improvements in Cirrhotic Patients
• Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit
• Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis
• Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)
• Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effects
• Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial
• Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement
• Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis
• Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant
• L-ornithine L-aspartate in Overt Hepatic Encephalopathy
• Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis
• Difference in Efficacy Between Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis Patients
• A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compens
• VSL#3 and Spontaneous Bacterial Peritonitis
• Telbivudine Renoprotective Effect in Patients With HBV-related Liver Cirrhosis
• Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation
• Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis
• An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension
• Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis
• Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)
• Probiotics for Liver Cirrhosis With Portal Hypertension
• Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis
• Effect of Tolvaptan on Cognitive Function in Cirrhosis
• Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis
• Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis
• Keyhole Limpet Hemocyanin in Chronic Hepatitis C
• Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis
• Treatment of Muscle Cramps in Patients With Liver Cirrhosis
• Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis
• Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
• Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation
• Proton Pump Inhibitors and Dysbiosis in Cirrhosis
• Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension
• The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS
• Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis
• Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding
• Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody
• Effects of Somatostatin on Post-endoscopic Portal Hemodynamic in Cirrhotic Patients With Esophageal Gastric Varices
• Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study
• A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid
• Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)
• Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency
• Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for Acute Variceal Bleeding in Patients With Advanced Cirrhosis
• Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis
• Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites
• Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites
• Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection
• Mechanism and the Effect of Midodrine on Portal Pressures in Patients With Cirrhosis
• Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasone
• A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol
• A Randomized Trial of GVS Alone vs. Propranolol
• Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis
• Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis
• Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.
• Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis
• Hemodynamic Effect of Simvastatin With Beta Blockers in Clinical Portal Hypertension
• A Study Evaluating the Efficacy and Safety of Pregabalin Against Frequent Muscle Cramp in Patients With Liver Cirrhosis
• Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LC
• Pentoxifylline for Primary Biliary Cirrhosis
• Mesenchymal Stem Cells Treat Liver Cirrhosis
• Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection
• Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients
• Allogenic Bone Marrow Stem Cells Transplantation in Patients With Liver Cirrhosis
• Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis
• A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection
• Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in Cirrhosis
• Early Primary Prophylaxis of Esophageal Varices
• Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
• Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial
• Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis
• Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy
• Probiotics for Portal Hypertension
• Midodrine and Albumin for Cirrhotic Patients With Functional Renal Impairment
• Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy
• Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding
• Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure
• Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4
• A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
• Bone Mesenchymal Stem Cell (BMSC) Transplantation in Liver Cirrhosis Via Portal Vein
• Effect of Candesartan in Alcoholic Liver Fibrosis
• Propofol Versus Midazolam and Fentanyl for Diagnostic and Screening Colonoscopy in Patients With Advanced Liver Disease
• Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.
• Endoscopic Band Ligation (EBL) Versus Propranolol for Primary Prophylaxis of Variceal Bleeding
• Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis
• Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)
• A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosis
• Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With Cirrhosis
• Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis
• Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)
• Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin
• Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers
• Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers
• Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis
• Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction
• Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)
• Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis
• Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity.
• Beta-blockers for Prevention Of Growth Of Small Esophageal Varices In Cirrhosis: An Randomized Controlled Trial (RCT)
• Rifaximin Versus Lactulose in Renal Failure
• Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)
• Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome
• Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome
• Spironolactone Versus Spironolactone Plus Furosemide (SVSSF)
• Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function
• Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)
• Role of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized Placebo Control Trial
• Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis
• Terlipressin in Septic Shock in Cirrhosis
• Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension
• A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic Patients
• Moexipril for Primary Biliary Cirrhosis
• Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis
• Use of Fenofibrate for Primary Biliary Cirrhosis
• Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
• Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis
• Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding
• A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis
• Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)
• Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
• TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis
• Efficacy of Baclofen in the Treatment of Alcohol Addiction
• Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis
• Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites
• Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites
• Satavaptan Dose-Ranging Study in the Prevention of Ascites
• Study of Combivir for Patients With Primary Biliary Cirrhosis
• Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients
• Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid
• Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis
• Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)
• Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)
• Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
• Initial Study of Rituximab to Treat Primary Biliary Cirrhosis
• Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis
• Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
• Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)
• Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis
• Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis
• Banding Versus Propranolol for Primary Prophylaxis of Variceal Bleeding
• Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis
• Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
• Probiotics for the Prevention of Major Complications of Cirrhosis
• A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)
• Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis
• Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C
• Steroid Free Immunosuppression in Liver Transplantation
• Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin
• Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
• The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
• A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.
• Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
• Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus
• Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C
• DOCICAR: Cardiac Dysfunction in Cirrhosis
• Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects
• Development of a Breath Test for Monitoring Patients With Liver Disease
• Prevention of Decompensation in Liver Cirrhosis
• Selenium Supplementation of Patients With Cirrhosis
• Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection
• Study of Long-term Peg Intron vs. Colchicine in Non-responders.
• Urotensin II and Vascular Tone in Cirrhosis
• Clinical Trial of Pentoxifylline in Patient With Cirrhosis
• Use of NovoSeven® in Active Variceal Bleeding
• Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer
• SAMe to Treat Biliary Cirrhosis Symptoms
• Albumin Administration in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
• Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C
• Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C
• Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites
• Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis
• Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis
• Treatment of Cholestatic Pruritus With Sertraline
• Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis
• PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)
• Prevention of Esophageal Varices by Beta-Adrenergic Blockers
• Ursodiol-Methotrexate for Primary Biliary Cirrhosis
• Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
• Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal Function, Vasoactive Systems and Endotoxemia
• Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
• Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis
• Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis
• Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis
• Prevention of Esophageal Varices by Beta-Adrenergic Blockers
• Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis